ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
-0,80%
Bitcoin
67 308,70
-1,54%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Senesco Technologies (SNT)

  7. Senesco Technologies (SNT) Actualités

SNT

Senesco (SNT)

Senesco Technologies
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:SNT
DateHeureSourceTitreSymboleSociété
23/11/201218h50Edgar (US Regulatory)(25-NSE)AMEX:SNTSenesco Technologies
23/11/201218h50Edgar (US Regulatory)(25-NSE)AMEX:SNTSenesco Technologies
21/11/201217h43Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)AMEX:SNTSenesco Technologies
21/11/201217h42Edgar (US Regulatory)Current report filing (8-K)AMEX:SNTSenesco Technologies
21/11/201217h42Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SNTSenesco Technologies
16/11/201223h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
16/11/201223h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
16/11/201223h20Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)AMEX:SNTSenesco Technologies
14/11/201220h58Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:SNTSenesco Technologies
14/11/201220h58Edgar (US Regulatory)Quarterly Report (10-q)AMEX:SNTSenesco Technologies
26/10/201212h37Edgar (US Regulatory)Amended Annual Report (10-K/A)AMEX:SNTSenesco Technologies
28/09/201217h58Edgar (US Regulatory)Annual Report (10-K)AMEX:SNTSenesco Technologies
09/07/201223h23PR Newswire (US)Life Sciences Companies Webcast Live to Online Investors, July 12th, at RetailInvestorConferences.comAMEX:SNTSenesco Technologies
02/07/201221h51Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)AMEX:SNTSenesco Technologies
12/06/201215h00PR Newswire (US)NYSE Companies' and NASDAQ Companies' June 7th Investor Presentations Now Available at RetailInvestorConferences.comAMEX:SNTSenesco Technologies
06/06/201219h30PR Newswire (US)Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on June 7thAMEX:SNTSenesco Technologies
06/06/201200h43PR Newswire (US)NYSE Companies and NASDAQ Companies Meet to Webcast Live, June 7th, at RetailInvestorConferences.comAMEX:SNTSenesco Technologies
04/06/201214h30Business WireSenesco Provides SNS01-T Update on Phase 1b/2a Multiple Myeloma TrialAMEX:SNTSenesco Technologies
30/05/201216h00Business WireSenesco’s SNS01-T to be Presented During Poster Session at 2012 Annual Meeting of the American Society of Clinical OncologyAMEX:SNTSenesco Technologies
23/05/201214h30Business WireSenesco’s SNS01 is a Potent Regulator of Programmed Cell Death and Tumor Growth in Murine Models of Multiple MyelomaAMEX:SNTSenesco Technologies
15/05/201214h30Business WireSenesco Technologies Reports Fiscal 2012 Third Quarter ResultsAMEX:SNTSenesco Technologies
14/05/201214h30Business WireSenesco to Present SNS01-T, an eIF5A-based Nanoparticle in a Phase 1b/2a Trial to Treat Multiple Myeloma, is Effective in Mod...AMEX:SNTSenesco Technologies
01/05/201214h30Business WireCombination of Lenalidomide and SNS01-T Effective in Cancer ModelAMEX:SNTSenesco Technologies
24/04/201220h08Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:SNTSenesco Technologies
19/03/201219h26Edgar (US Regulatory)Statement of Ownership (SC 13G)AMEX:SNTSenesco Technologies
12/03/201219h20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:SNTSenesco Technologies
07/03/201214h30Business WireSenesco Adds Additional Clinical Site to Evaluate SNS01-T in Multiple MyelomaAMEX:SNTSenesco Technologies
02/03/201214h42Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)AMEX:SNTSenesco Technologies
02/03/201214h30Business WireSenesco Announces Additional $1.0 Million Equity FinancingAMEX:SNTSenesco Technologies
01/03/201214h30Business WireSenesco Adds Second Clinical Site to Evaluate SNS01-T in Multiple MyelomaAMEX:SNTSenesco Technologies
 Showing the most relevant articles for your search:AMEX:SNT

Dernières Valeurs Consultées

USOTC
LABFF
Laboratorios Farmaceutic... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés